Does Medicare Cover Dementia Care?

There are really two questions hiding inside “Does Medicare cover dementia care?” — and families almost always assume the answer to one applies to the other.

The first question is: will Medicare pay for the medical care a person with dementia needs? Diagnosis, neurologist visits, brain scans, medications, the new infusion drugs, hospital stays, end-of-life care. The answer there is largely yes, and Medicare’s dementia coverage has actually gotten meaningfully better in the past two years.

The second question is: will Medicare pay for the care in the everyday sense — the supervision, the help getting dressed, the someone-has-to-be-here-all-the-time that dementia demands as it progresses? The answer there is almost entirely no. And because that second kind of care is what costs families $60,000 to $100,000 a year, the gap is enormous.

This page separates the two so you know exactly which costs Medicare absorbs and which ones you have to plan for.

What Medicare covers: the medical side of dementia

Medicare’s coverage of the clinical management of dementia is broad and, in 2026, surprisingly good.

Diagnosis and monitoring (Part B).

• The annual Medicare wellness visit now includes a cognitive impairment assessment at no cost.
• Neurological evaluations, specialist visits, and follow-up appointments are covered with the standard 20% coinsurance.
• Diagnostic imaging — MRI to rule out other causes, and amyloid PET scans where indicated — is covered.
• Lab work, including the newer plasma biomarker blood tests that are coming into clinical use, is covered.

Medications (Part D and Part B).

• The older symptomatic drugs — donepezil (Aricept), rivastigmine (Exelon), galantamine (Razadyne), and memantine (Namenda) — are covered under Part D, almost always on Tier 1 or Tier 2 with low copays.
• The newer disease-modifying monoclonal antibodies — Leqembi (lecanemab) and Kisunla (donanemab) — are covered under Part B for qualifying early-stage patients, because they’re infused in a clinic. They carry the standard 20% coinsurance, which Medigap covers.

Care coordination (the GUIDE program). Launched in July 2024, GUIDE is the most important recent addition to Medicare’s dementia coverage. Participating practices provide a care navigator, 24/7 phone access to dementia expertise, caregiver training, and up to $2,500/year of respite care — with no cost-sharing. We’ll come back to this because it’s the most underused benefit in dementia care.

Hospital and short-term skilled care (Part A).

• Hospital admissions are covered with the usual Part A deductible and structure.
• After a qualifying 3-day inpatient hospital stay, up to 100 days in a skilled nursing facility for rehab is covered (days 1–20 at $0, days 21–100 at $209.50/day in 2026).

Hospice (Part A). When a person with advanced dementia qualifies for hospice (a prognosis of six months or less), Medicare covers the entire hospice layer — nursing visits, aide services, social work, chaplaincy, medications related to the terminal diagnosis, and respite care for the caregiver — wherever the person lives.

Home health (Part A/B). If the person is homebound and needs intermittent skilled care, Medicare home health covers skilled nursing and therapy visits at $0 coinsurance. This is skilled care, not full-time supervision — an important distinction we cover below.

What Medicare doesn’t cover: the custodial side

Here’s the gap, stated plainly. Medicare does not pay for:

• A home aide who comes to supervise, bathe, dress, or keep your parent safe for hours each day
• The monthly fee at an assisted living or memory care facility
• Long-term nursing home placement when the reason is dementia supervision rather than a skilled medical need
• Round-the-clock supervision of any kind

All of this is classified as custodial care — care that helps with activities of daily living and doesn’t require a licensed medical professional to deliver. Medicare excludes custodial care by statute. The exclusion applies no matter how medically necessary the care is, no matter how advanced the dementia, no matter that leaving the person alone is genuinely dangerous.

This is the part that blindsides families, because the everyday meaning of “care” and Medicare’s definition of covered “care” are almost opposites. The supervision a dementia patient needs most is exactly what Medicare covers least.

The skilled-vs-custodial line, with dementia examples

The distinction Medicare draws is between skilled care (covered) and custodial care (not covered). Dementia sits awkwardly across that line:

• A nurse visiting twice a week to manage a wound or adjust medications: skilled, covered.
• An aide staying all afternoon so your father doesn’t wander out the front door: custodial, not covered.
• Physical therapy after a dementia-related fall and hip fracture: skilled, covered (Part B, or Part A in a SNF after hospitalization).
• Help with bathing and dressing because your mother can no longer do it safely: custodial, not covered.

Many families discover that the help they actually need — the second and fourth examples — is the help Medicare won’t pay for, while the help it will pay for (skilled nursing visits) is intermittent and time-limited.

How families actually pay for the custodial gap

Because the custodial gap is so large, it’s worth knowing the realistic funding sources up front:

1. Personal income and savings. Most families start here and exhaust liquid assets within two to four years at full custodial-care prices.
2. Long-term care insurance, if purchased before the diagnosis. Cognitive impairment is a standard claim trigger.
3. VA Aid and Attendance for wartime veterans and surviving spouses who meet financial criteria — roughly up to $2,300/month for a veteran in 2026.
4. Medicaid, once assets are depleted to the eligibility threshold. Most states have Home and Community-Based Services waivers that can pay for in-home or assisted-living personal care; coverage and waiting lists vary by state.
5. Hospice, in the final stage, which overlays the full medical and supportive layer at near-zero cost.

A common path: pay privately while assets last, work with an elder law attorney on Medicaid planning before money runs out, and use VA benefits if eligible. Start this conversation early — the worst time to figure it out is during a crisis.

The GUIDE program is the benefit nobody uses

If you take one action item from this page, make it this: find out whether your parent’s medical practice participates in GUIDE.

The Guiding an Improved Dementia Experience model pays participating practices a monthly Medicare fee to deliver comprehensive dementia care management. For your family, that means:

• A dedicated care navigator who knows your parent’s case
• A 24/7 phone line staffed with dementia-care expertise
• Structured caregiver education and support
• Up to $2,500 per year in respite care — in-home, adult day services, or short-term residential

There’s no cost-sharing for traditional Medicare beneficiaries. The respite benefit alone is worth more than most families realize, because respite is otherwise one of the hardest things to fund.

Ask your parent’s neurologist or primary care physician directly: “Are you a GUIDE participant?” If they’re not, ask whether there’s a participating practice nearby accepting patients. Note: GUIDE is for people in traditional Medicare; if your parent is in a Medicare Advantage plan, ask the plan what equivalent dementia care management it offers.

The new drugs and what they change

Leqembi and Kisunla are the first treatments that modestly slow the progression of early Alzheimer’s disease rather than just managing symptoms. Medicare covers both under Part B for qualifying patients (confirmed early-stage Alzheimer’s pathology, enrollment in a CMS data registry). For an Original Medicare beneficiary with a Medigap policy, the out-of-pocket cost is effectively zero after the supplement absorbs the 20% coinsurance.

These drugs don’t reverse dementia and aren’t right for everyone — they carry real risks and an infusion burden — but from a coverage standpoint, the door is open. Whether to walk through it is a clinical decision for your family and the neurologist.

What to do next

If you’re early in this:

1. Get an accurate, documented diagnosis — it unlocks GUIDE and the new drugs.
2. Ask whether the treating practice participates in GUIDE.
3. Map your custodial-care funding sources now, while everyone can still participate in the planning.
4. Talk to an elder law attorney about the Medicaid timeline before assets are depleted.

For the residency-cost side specifically, see our deep dives on memory care coverage, nursing home coverage, in-home care, and respite care. And if your parent’s diagnosis is specifically Alzheimer’s, our Alzheimer’s coverage page covers the drug and treatment specifics.